PATENT CLAIM ANALYSIS

Application Number: 16107426
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "456000"]

Abstract:
The present invention relates to compositions and methods for prophylactic and/or therapeutic treatment of conditions related to mitochondrial function. In various aspects, the present invention comprises administering one or more compounds selected from the group consisting of epicatechin, an epicatechin derivative, catechin, a catechin derivative, nicorandil, and a nicorandil derivative in an amount effective to ameliorate mitochondrial toxicity caused by administration of a chemical, food, or drug.

Claim (Index 25):
The method of  claim 22 , wherein the drug is selected from the group consisting of:\n a. a corticosteroid; b. metformin or phenformin; c. a thiozolidinedione; d. a statin; e. ibuprofen celecoxib, diclofenac, indomethacin, mefenamic acid, meloxicam, naproxen, or piroxicam, f. a fibrate g. a chemotherapeutic; and h. an antipsychotic.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.5098
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13489317', '14237167', '14387117', '14808534', '11766224']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7835277596893413
- 35 USC 102 Novelty (BERT): 0.5650015270625914
- Combined Prediction Score: 0.7616751364266664
- Mean Citation Score: 246.68583
- Max Citation Score: 454.12265
- Similarity Product: 343.1074270095796

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test